Arsenal Capital Partners
Overview
Arsenal Capital Partners is a private equity firm that specializes in investments in middle-market industrial growth and healthcare companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| hc1 Insights, Inc. | Jan 2025 | VC Round | Co-investor |
| Epic Sciences | Apr 2023 | Series G | Lead |
| Deck Commerce | Jul 2018 | VC Round | Lead |
| Bonfyre | Jun 2016 | Series A | Co-investor |
| Harbor MedTech, Inc. | Sep 2017 | Series B Extension | Co-investor |
For institutional investors. Book with your work email.
Key People
Terrence Mullen
Co-Founder And Managing Partner
Dan Bruck
Managing Director
Taylor Holland
Managing Director
BG Porter
Operating Partner
George Abd
Operating Partner
Jeremy Goldberg
Operating Partner, Healthcare
Marc R. Tremblay
Operating Partner
Mark A. Goldberg
Operating Partner
Martin Coulter
Operating Partner
Raymond H Hill
Operating Partner
Sal Gagliardo
Operating Partner
Salvatore Gagliardo
Operating Partner
Timothy Zappala
Operating Partner
Trace Devanny
Operating Partner
Joe Rooney
Investment Partner
Roy Seroussi
Investment Partner
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Arsenal Capital Partners based?
Arsenal Capital Partners is headquartered in New York City, New York, United States.
When was Arsenal Capital Partners founded?
Arsenal Capital Partners was founded in 2000.
How many portfolio companies does Arsenal Capital Partners have?
Arsenal Capital Partners has 29 portfolio companies in Caplight's dataset.
What are some companies in Arsenal Capital Partners's portfolio?
Portfolio companies visible on Caplight include hc1 Insights, Inc., Epic Sciences, Deck Commerce, Bonfyre, Harbor MedTech, Inc..
What was Arsenal Capital Partners's most recent investment shown here?
Arsenal Capital Partners's most recent investment in this portfolio sample was in hc1 Insights, Inc. in 2025.
What sectors does Arsenal Capital Partners focus on?
Arsenal Capital Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Mobility, Transportation & Logistics, Mobility, Transportation & Logistics, Frontier & Industrial Tech, Enterprise Software, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Enterprise Software, Consumer & Commerce, Energy & Sustainability, Healthcare & Life Sciences, Frontier & Industrial Tech, FinTech, Energy & Sustainability, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, Enterprise Software, Energy & Sustainability, Consumer & Commerce, Enterprise Software, FinTech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Mobility, Transportation & Logistics, Healthcare & Life Sciences, Enterprise Software, Energy & Sustainability, Healthcare & Life Sciences, Consumer & Commerce, Frontier & Industrial Tech.
What company stages does Arsenal Capital Partners focus on?
Arsenal Capital Partners typically invests at the MultiStage stage.
What is Arsenal Capital Partners's AUM?
Arsenal Capital Partners's assets under management are estimated between $10.0B and $100.0B.